Insider · CIK 0001212669

DERBYSHIRE ADAM C

Reports to the SEC for 1 company · MORRISVILLE, NC

sec.gov

Transactions

Companies

Filings

CIK

0001212669

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2014-08-22	SALIX PHARMACEUTICALS LTDA Award	EVP Finance/CFO	AAward	+20.8K sh	$158.30	+$3.29M	218,463
2014-07-01	SALIX PHARMACEUTICALS LTDF Tax Payment	EVP Finance/CFO	FTax Payment	−2,458 sh	$123.35	−$303K	197,700
2014-01-09	SALIX PHARMACEUTICALS LTDS Sale	EVP Finance/CFO	SSale	−2,400 sh	$91.95	−$221K	206,996
2014-01-09	SALIX PHARMACEUTICALS LTDS Sale	EVP Finance/CFO	SSale	−27.6K sh	$91.44	−$2.52M	179,395
2014-01-09	SALIX PHARMACEUTICALS LTDOption to Buy Common StockM Exercise/Conversion	EVP Finance/CFO	MExercise/Conversion	−30K sh	—	—	0
2014-01-09	SALIX PHARMACEUTICALS LTDM Exercise/Conversion	EVP Finance/CFO	MExercise/Conversion	+30K sh	$18.87	+$566K	209,396
2014-01-02	SALIX PHARMACEUTICALS LTDF Tax Payment	EVP Finance/CFO	FTax Payment	−9,135 sh	$89.94	−$822K	179,395
2013-07-01	SALIX PHARMACEUTICALS LTDF Tax Payment	EVP Finance/CFO	FTax Payment	−6,362 sh	$66.15	−$421K	188,530
2013-04-18	SALIX PHARMACEUTICALS LTDA Award	EVP Finance/CFO	AAward	+24.4K sh	$48.70	+$1.19M	194,892
2013-01-02	SALIX PHARMACEUTICALS LTDF Tax Payment	EVP Finance/CFO	FTax Payment	−6,130 sh	$40.47	−$248K	170,471
2012-12-26	SALIX PHARMACEUTICALS LTDM Exercise/Conversion	EVP Finance/CFO	MExercise/Conversion	+90K sh	$8.00	+$720K	236,601
2012-12-26	SALIX PHARMACEUTICALS LTDOption to Buy Common StockM Exercise/Conversion	EVP Finance/CFO	MExercise/Conversion	−90K sh	—	—	0
2012-12-26	SALIX PHARMACEUTICALS LTDS Sale	EVP Finance/CFO	SSale	−60K sh	$41.44	−$2.49M	176,601
2012-07-02	SALIX PHARMACEUTICALS LTDCommon StockD Disposition to Issuer	EVP Finance/CFO	DDisposition to Issuer	−20K sh	—	—	—
2012-07-02	SALIX PHARMACEUTICALS LTDF Tax Payment	EVP Finance/CFO	FTax Payment	−6,248 sh	$54.44	−$340K	146,601
2012-04-25	SALIX PHARMACEUTICALS LTDA Award	EVP Finance/CFO	AAward	+21.7K sh	—	—	152,849
2012-02-28	SALIX PHARMACEUTICALS LTDS Sale	EVP Finance/CFO	SSale	−12.6K sh	$50.09	−$631K	131,138
2012-02-28	SALIX PHARMACEUTICALS LTDOption to Buy Common StockM Exercise/Conversion	EVP Finance/CFO	MExercise/Conversion	−12.6K sh	—	—	0
2012-02-28	SALIX PHARMACEUTICALS LTDM Exercise/Conversion	EVP Finance/CFO	MExercise/Conversion	+12.6K sh	$4.07	+$51.2K	143,738
2012-02-13	SALIX PHARMACEUTICALS LTDOption to Buy Common StockM Exercise/Conversion	EVP Finance/CFO	MExercise/Conversion	−12.9K sh	—	—	12,600
2012-02-13	SALIX PHARMACEUTICALS LTDM Exercise/Conversion	EVP Finance/CFO	MExercise/Conversion	+12.9K sh	$4.07	+$52.4K	144,029
2012-02-13	SALIX PHARMACEUTICALS LTDS Sale	EVP Finance/CFO	SSale	−12.9K sh	$50.00	−$645K	131,138
2012-02-03	SALIX PHARMACEUTICALS LTDOption to Buy Common StockM Exercise/Conversion	EVP Finance/CFO	MExercise/Conversion	−776 sh	—	—	25,491
2012-02-03	SALIX PHARMACEUTICALS LTDM Exercise/Conversion	EVP Finance/CFO	MExercise/Conversion	+776 sh	$4.07	+$3,155.682	131,914
2012-02-03	SALIX PHARMACEUTICALS LTDS Sale	EVP Finance/CFO	SSale	−776 sh	$50.00	−$38.8K	131,138
2012-01-18	SALIX PHARMACEUTICALS LTDM Exercise/Conversion	EVP Finance/CFO	MExercise/Conversion	+375 sh	$4.07	+$1,524.975	131,513
2012-01-18	SALIX PHARMACEUTICALS LTDOption to Buy Common StockM Exercise/Conversion	EVP Finance/CFO	MExercise/Conversion	−375 sh	—	—	26,267
2012-01-18	SALIX PHARMACEUTICALS LTDS Sale	EVP Finance/CFO	SSale	−375 sh	$50.00	−$18.8K	131,138
2012-01-18	SALIX PHARMACEUTICALS LTDS Sale	EVP Finance/CFO	SSale	−375 sh	$4.07	−$1,524.975	131,138
2012-01-17	SALIX PHARMACEUTICALS LTDS Sale	EVP Finance/CFO	SSale	−3,358 sh	$50.06	−$168K	131,138
2012-01-17	SALIX PHARMACEUTICALS LTDM Exercise/Conversion	EVP Finance/CFO	MExercise/Conversion	+3,358 sh	$4.07	+$13.7K	134,496
2012-01-17	SALIX PHARMACEUTICALS LTDOption to Buy Common StockM Exercise/Conversion	EVP Finance/CFO	MExercise/Conversion	−3,358 sh	—	—	26,642
2012-01-03	SALIX PHARMACEUTICALS LTDF Tax Payment	EVP Finance/CFO	FTax Payment	−2,852 sh	$47.85	−$136K	131,138
2011-07-01	SALIX PHARMACEUTICALS LTDF Tax Payment	EVP Finance/CFO	FTax Payment	−11.2K sh	$39.83	−$448K	133,990
2011-04-25	SALIX PHARMACEUTICALS LTDA Award	EVP Finance/CFO	AAward	+26K sh	—	—	145,232
2010-07-19	SALIX PHARMACEUTICALS LTDA Award	EVP Finance/CFO	AAward	+19.5K sh	—	—	119,277
2010-07-01	SALIX PHARMACEUTICALS LTDF Tax Payment	EVP Finance/CFO	FTax Payment	−8,614 sh	$39.03	−$336K	99,757
2010-06-13	SALIX PHARMACEUTICALS LTDCommon StockD Disposition to Issuer	EVP Finance/CFO	DDisposition to Issuer	−100K sh	—	—	—
2009-12-09	SALIX PHARMACEUTICALS LTDS Sale	EVP Finance/CFO	SSale	−5,000 sh	$23.10	−$116K	108,371
2009-12-09	SALIX PHARMACEUTICALS LTDOption to Buy Common StockM Exercise/Conversion	EVP Finance/CFO	MExercise/Conversion	−5,000 sh	—	—	0
2009-12-09	SALIX PHARMACEUTICALS LTDM Exercise/Conversion	EVP Finance/CFO	MExercise/Conversion	+5,000 sh	$1.13	+$5,666.5	113,371
2009-12-02	SALIX PHARMACEUTICALS LTDS Sale	EVP Finance/CFO	SSale	−5,000 sh	$23.37	−$117K	108,371
2009-12-02	SALIX PHARMACEUTICALS LTDM Exercise/Conversion	EVP Finance/CFO	MExercise/Conversion	+5,000 sh	$1.13	+$5,666.5	113,371
2009-12-02	SALIX PHARMACEUTICALS LTDOption to Buy Common StockM Exercise/Conversion	EVP Finance/CFO	MExercise/Conversion	−5,000 sh	—	—	5,000
2009-11-25	SALIX PHARMACEUTICALS LTDOption to Buy Common StockM Exercise/Conversion	EVP Finance/CFO	MExercise/Conversion	−5,000 sh	—	—	10,000
2009-11-25	SALIX PHARMACEUTICALS LTDS Sale	EVP Finance/CFO	SSale	−5,000 sh	$23.58	−$118K	108,371
2009-11-25	SALIX PHARMACEUTICALS LTDM Exercise/Conversion	EVP Finance/CFO	MExercise/Conversion	+5,000 sh	$1.13	+$5,666.5	113,371
2009-11-18	SALIX PHARMACEUTICALS LTDOption to Buy Common StockM Exercise/Conversion	EVP Finance/CFO	MExercise/Conversion	−5,000 sh	—	—	15,000
2009-11-18	SALIX PHARMACEUTICALS LTDM Exercise/Conversion	EVP Finance/CFO	MExercise/Conversion	+5,000 sh	$1.13	+$5,666.5	113,371
2009-11-18	SALIX PHARMACEUTICALS LTDS Sale	EVP Finance/CFO	SSale	−5,000 sh	$21.05	−$105K	108,371

Recent filings

Accepted (ET)
Aug 264
SALIX PHARMACEUTICALS LTD0001209191-14-054520
SEC(opens sec.gov)
Jul 34
SALIX PHARMACEUTICALS LTD0001209191-14-046136
SEC(opens sec.gov)
Jan 134
SALIX PHARMACEUTICALS LTD0001209191-14-003013
SEC(opens sec.gov)
Jan 64
SALIX PHARMACEUTICALS LTD0001209191-14-001838
SEC(opens sec.gov)
Jul 34
SALIX PHARMACEUTICALS LTD0001209191-13-035608
SEC(opens sec.gov)
Apr 224
DERBYSHIRE ADAM C0001209191-13-022200
SEC(opens sec.gov)
Jan 44
DERBYSHIRE ADAM C0001209191-13-002110
SEC(opens sec.gov)
Dec 284
DERBYSHIRE ADAM C0001209191-12-059669
SEC(opens sec.gov)
Jul 54
DERBYSHIRE ADAM C0001209191-12-037383
SEC(opens sec.gov)
Apr 274
DERBYSHIRE ADAM C0001209191-12-024601
SEC(opens sec.gov)
Mar 14
DERBYSHIRE ADAM C0001209191-12-014562
SEC(opens sec.gov)
Feb 154
DERBYSHIRE ADAM C0001209191-12-010556
SEC(opens sec.gov)

Companies

SALIX PHARMACEUTICALS LTDEVP Finance/CFO

Address

1700 PERIMETER PARK DRIVE

MORRISVILLE, NC, 27560